Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Mabs
|
June 18, 2015
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily C Piccione, Silvia Juarez, Jie Liu, et al.
Oncoimmunology
|
December 10, 2013
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants
Kipp Weiskopf, Aaron M Ring, Peter J Schnorr, et al.
Microbiology Spectrum
|
October 21, 2016
Myeloid Cell Origins, Differentiation, and Clinical Implications
Kipp Weiskopf, Peter J Schnorr, Wendy W Pang, et al.
Oncoimmunology
|
July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
Badreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Haematologica
|
April 23, 2026
Immune evasion in primary central nervous system lymphoma: macrophage and T cell roles in response to immunotherapy
Carlota Pagès-Geli, Daniel Medina-Gil, Patricia Fernández-Guzmán, et al.
Cell Reports
|
August 2, 2016
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
Michael Ngo, Arum Han, Anita Lakatos, et al.
Chemistry & Biology
|
May 29, 2012
A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages
Martijn Verdoes, Laura E Edgington, Ferenc A Scheeren, et al.
Journal of Oncology Practice
|
August 12, 2016
Acute, Unilateral Breast Toxicity From Gemcitabine in the Setting of Thoracic Inlet Obstruction
Kipp Weiskopf, David Creighton, Thomas Lew, et al.
The Journal of Biological Chemistry
|
April 4, 2015
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis
Chia Chi M Ho, Nan Guo, Jonathan T Sockolosky, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Mabs
|
June 18, 2015
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily C Piccione, Silvia Juarez, Jie Liu, et al.
Oncoimmunology
|
December 10, 2013
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants
Kipp Weiskopf, Aaron M Ring, Peter J Schnorr, et al.
Microbiology Spectrum
|
October 21, 2016
Myeloid Cell Origins, Differentiation, and Clinical Implications
Kipp Weiskopf, Peter J Schnorr, Wendy W Pang, et al.
Oncoimmunology
|
July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
Badreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Haematologica
|
April 23, 2026
Immune evasion in primary central nervous system lymphoma: macrophage and T cell roles in response to immunotherapy
Carlota Pagès-Geli, Daniel Medina-Gil, Patricia Fernández-Guzmán, et al.
Cell Reports
|
August 2, 2016
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
Michael Ngo, Arum Han, Anita Lakatos, et al.
Chemistry & Biology
|
May 29, 2012
A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages
Martijn Verdoes, Laura E Edgington, Ferenc A Scheeren, et al.
Journal of Oncology Practice
|
August 12, 2016
Acute, Unilateral Breast Toxicity From Gemcitabine in the Setting of Thoracic Inlet Obstruction
Kipp Weiskopf, David Creighton, Thomas Lew, et al.
The Journal of Biological Chemistry
|
April 4, 2015
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis
Chia Chi M Ho, Nan Guo, Jonathan T Sockolosky, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Page
of 5